Key Takeaways
Every innovative life science company knows that social media advertising is where it’s at these days. What was previously an arena reserved for targeting millennials who were once teenagers and young adults is now an all-ages playground. Everyone you know is on social media platforms, from Gen Z nieces and nephews to Baby Boomer relatives.
Ninety percent of people use these platforms to keep up with trends, and 60% of product discovery happens through them. So, as marketing opportunities have opened up to reach anyone through a tiny device that fits the palm of their hand, so have the risks of misrepresentation.
Regulators are also catching up. Although TV, newspapers, and billboards used to be the prime targets of their scrutiny, social media is now being examined in microscopic detail. From a deleted comment with unauthorized product usage to an employee’s post about the brand, social media presence for a life science company, whether in the health and human services or pharmaceutical spaces, can be a minefield of warnings and lawsuits waiting to explode. But it doesn’t have to be that way with the proper risk management practices in place.
The “Big Three” Who Can Shut You Down
In the regulatory playing field, three referees are watching a business’s every move on social media platforms and making calls. Ultimately, they will be the ones to contact companies whenever they consider their posts have crossed lines or walk on tightropes.
The FDA
The Food and Drug Administration (FDA), which is also in charge of approving most health-related products for release into the market, keeps a watchful eye on social media movements it might consider to be misbranding. “Movements” as opposed to “posts” is an important distinction to make because comments, reposts, quotes, and other forms of brand communication also fall under its jurisdiction.
This agency usually sends cease-and-desist letters (as more regularly enforced by the current administration), requiring companies to immediately rectify untrue claims about their products or services or failing to disclose side effects and risks, or face penalties. Another, more traditionally enforced, FDA regulations practice is sending warning letters, which allows companies to make changes to their statements without penalties. This is why following FDA guidance documents, even for social media campaigns, is paramount.
These warning letters are commonly seen as flare guns in the sky for hungry lawyers to start class action lawsuits against companies—something risk managers must look out for.
The FTC
The Federal Trade Commission (FTC), much like the FDA, also scrutinizes the advertisement of any health-related product on social media platforms. Unlike the FDA, however, the FTC goes beyond labels and FDA-approved prescription drugs, and prioritizes consumer protection—all products pertaining to health fall under its jurisdiction, from prescription drugs to dietary supplements (this was updated in the commission’s 2022 Health Compliance Guidance).
The DOJ
The Department of Justice (DOJ) prosecutes any company making false or misleading claims about its products, including life science organizations. In addition, it also enforces the False Claims Act (FCA), which allows the government or people acting on behalf of it to sue businesses in the case of submitting false claims to the government.
For instance, this can look like paying influencers to promote a product without disclosing it, much like doctors do specific prescription drug promotion due to financial incentives.
Surprisingly, 2025 was a record year for FCA enforcement—the DOJ’s way of letting life science companies know they’re keeping a close eye on them.
Managing Disclosure Risks with Character Space Limitations
Suppose a pharmaceutical company proudly shares a success story. It includes the patient’s ailments and how they recovered or were able to lead a better life through the product’s benefits. Everything is shown in a positive light, as social media marketing often goes, but they’ve missed an important detail, and a main target of regulatory scrutiny.
One of the easiest social media mistakes a life science company can make is failing to disclose risk and benefit information. The simple act of skipping over the risks and side effects of a product can land companies in serious trouble with the FDA and FTC. By posting a success story but failing to mention side effects, whether due to social media character limits or simple oversight in the social media marketing campaign, is like walking into a material misrepresentation trap.
The Specifics for Health Companies
For instance, if the benefits are displayed in big, bright letters and the risks are in tiny, grey text at the bottom, insurance auditors consider this a failure. Another example is including a “link in bio for more details” line without explicit risk disclosure on the caption or post. Overall, risk managers prefer the warning to be evident in the post and disclosed with easily understandable language so users can’t miss it or misunderstand it.
Just last year, the FDA issued a warning letter to Sprout Pharmaceuticals, a company that makes medicine specifically for women. Their most popular product, a drug that helps women with low libido, was being misbranded on social media as they failed to disclose the potential risks. While trying to “harmlessly” promote their product, the company ended up being put under the spotlight for its lack of proper disclosure online.
Avoiding Unintentional Medical Advice in Direct Messages
Although it would generally be safe to hire healthcare professionals as community managers, the reality is that the candidate pool would be rather narrow. What’s true is that all social media staff should be experts in the product and be aware of compliance and regulations. At most, there must be a clear protocol to approve both posts and interactions with users.
The latter must be the most difficult one to oversee, as interactions can range from a repost to a quick direct message (DM) response. However, the repercussions of a harmless yet inaccurate interaction can get companies into trouble fast.
A customer might send a DM asking, “Can I use this for [unapproved use]?” Your social media manager might want to be helpful and say, “Sure!” However, this is considered off-label advice, and it can be a massive insurance liability.
On the other hand, if a user comments on a post saying the product made them sick, the clock starts. Companies usually have just 24 hours to log that as an adverse event. If the business misses it, it has broken the law, and its insurance might not cover the fallout.
Content Creator Insurance Guide
Medical Device Companies: Stick to the Script
Medical devices call for a different kind of rigor in how companies do social media strategy. That is, they must not stray away from the exact usage of their product when making a how-to for their social media channels, or their insurance might not pay the claim if somebody gets hurt.
What’s more, how others showcase their product is also the business’s responsibility. For instance, if someone buys a life science company’s hair removal laser and shows themselves using it to remove a mole instead, it’s the company that must rectify this information to avoid it from spreading. Otherwise, it could be walking into a product liability nightmare.
Ultimately, companies must monitor social media sites to spot any unauthorized use of their medical device and stop it before it spreads.
Influencers: Your Name, Their Mouth
Today, it’s nearly impossible to name a brand that hasn’t partnered with an influencer to connect with their niche more easily through a trusted voice in the community. In fact, 94% of organizations believe that influencer marketing brings more ROI than traditional digital advertising. And, while you’d be right to think that, hiring ambassadors external to your company can create another risk factor.
Whatever the influencer chooses to say in the video doing pharmaceutical advertising, or any other kind of health product marketing, can be directly linked back to the company, creating a vicarious liability that must be handled with care. Vetting storyboards and the final product before being posted is paramount in the industry.
While all promotional content must now explicitly inform the nature of the ad, health and drug advertising influencers must go the extra mile. Fair balance still applies to them, so all disclosures regarding product risks must be clarified in the content. The same goes for the company’s sales representatives or other employees posting about the product online, even if they aren’t directly hired as influencers or ambassadors.
The “Safety Net” (MLR and Backups)
Life sciences businesses promoting their products, whether it’s a medical device or a pill from a pharmaceutical company, on social media platforms must take a few extra steps to keep themselves and users safe. Thankfully, a path has already been laid before them to avoid issues through a pivotal company department—they just have to be proactive about the specific protocols and social media guidelines they must follow.
In the industry, Medical, Legal, Regulatory (MLR) teams are the immune system that keep life sciences businesses running despite the many looming risks surrounding them. This is their defense squad and best protector, whether we’re talking about audits, social media presence, or a user mishap.
Cyber Risk Management Guide
Such teams focus on recordkeeping, including what happens on the socials. For auditing reasons, organizations must archive every single post and its new variations, and the interactions below it—you must be able to prove exactly what your post looked like on Tuesday at 2:00 PM if a regulator asks three years from now.
The MLR team also supports companies when they need a kill switch, also known as what happens after a product recall. When the product needs to be pulled off the shelves, social media accounts must follow suit by shutting down any promotion for it.
Digital Privacy & Hacks
Fun social media strategies that would usually fly by in other industries need to go through a higher level of internal scrutiny before they see the light of day. This is why creating protocols and templates is so important in the life sciences field, allowing for efficiency while staying cautious before clicking “Post.”
To illustrate, a testimonial is usually a great way for businesses to showcase the real success of their product. The more specific, the more relatable and credible for followers. However, for life science organizations, sharing someone’s real story requires signing specific legal forms that allow you to share such a story, or risk violating HIPAA.
Moreover, the risk of a cyberattack in the industry goes beyond a data breach or operational shutdown (although those issues are bad enough in and of themselves). For the niche, getting their social media accounts hacked to post fake medical advice or other information that damages brand trust is an insurable loss that is quite hard to fix. This is why, on top of protecting systems and hardware, community managers should also follow strict login rules that make it more difficult for hackers to enter company accounts.
Why Bother? It’s About FDA Regulations and Beyond
The bottom line is, the safer you are, the more insurable you become. Having a playbook or checklist for your social media accounts shows you’re serious about protecting every single aspect of your company, even the easily overlooked online presence. Taking these extra precautions turns you into a lower risk, which simplifies the insurance process or gets you insured at all.
Playing by the rules will, ultimately, make you a more trustworthy company with online users by showing that you care about their well-being (not just overly promoting your product to get sales), and transform you into a safer, more profitable business—this attracts lower deductibles, too.
Insurance Rebuilt, End-to-End